Previous 10 | Next 10 |
NovoCure Limited (NVCR) Q3 2018 Earnings Conference Call October 25, 2018 08:00 AM ET Executives Ashley Cordova - Senior Vice President, Finance and Investor Relations Bill Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Wilco Groenhuysen - Chief Financial Of...
Gainers: TIS +20% . TBIO +17% . SNBR +17% . LJPC +17% . ATNI +16% . IMMY +15% . TWTR +15% . XLNX +15% . TRVG +14% . MORN +14% . More news on: Orchids Paper Products Company, Translate Bio, Sleep Number Corporation, Stocks on the move, , Top stock marke...
The following slide deck was published by NovoCure in conjunction with their 2018 Q3 earnings Read more ...
NovoCure ( NVCR ) Q3 results: Revenues: $64.8M (+29.3%); Net Loss: ($11.7M) (+1.7%); Loss Per Share: ($0.13) (unch). More news on: NovoCure, Healthcare stocks news, Earnings news and commentary, Read more ...
NovoCure (NASDAQ: NVCR ): Q3 GAAP EPS of -$0.13 beats by $0.02 . More news on: NovoCure, Earnings news and commentary, Healthcare stocks news, Read more ...
Quarterly net revenues of $64.8 million, representing 29 percent growth versus the third quarter 2017 and 5 percent growth versus the second quarter 2018 Humanitarian device exemption (HDE) application submitted to FDA for approval in malignant pleural mesothelioma Novocure (NASD...
Shares of NovoCure ( NVCR ) were trading at $18/share when I introduced them as "revolutionizing cancer treatment" and at $21/share when I called them a "high conviction" pick. Just a few months later, shares in NovoCure trade comfortably over $45/share and for good reason. NovoCure is see...
Novocure (NASDAQ: NVCR ) and Zai Lab (NASDAQ: ZLAB ) signs an exclusive license agreement for Tumor Treating Fields, including the brand name Optune, in Greater China and a global strategic development collaboration. More news on: NovoCure, Zai Lab Ltd., Healthcare stocks news, ...
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday , September 11. Cramer started the show by remembering the tragic events of Sept. 11, 2001 and the collapse of Lehman Brothers. Despite that, he repeated his mantra, "There is always a bull market ...
Zai Lab granted license to commercialize oncology platform technology Tumor Treating Fields, including the brand name Optune®, in China, Hong Kong, Macau and Taiwan Zai Lab will support enrollment of Chinese patients to certain clinical trials investigating Tumor Treating Fields, ...
News, Short Squeeze, Breakout and More Instantly...
2024-08-02 13:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-25 17:30:15 ET Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q2 2024 Earnings Call Jul 25, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: NovoCure (NVCR) Q2 2024 Earnings Call Transcript
Quarterly net revenues of $150 million, up 19% year-over-year, with 3,963 active patients on therapy as of June 30, 2024 Positive results from Phase 3 METIS trial in brain metastases from non-small cell lung cancer presented at ASCO 2024 Novocure (NASDAQ: NVCR) today reported fi...